InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Levitz Michael L, Chief Financial Officer. Insider active across 2 companies, notably Anika Therapeutics, Inc.. In total, 6 disclosures have been recorded. Total volume traded: €285k. The latest transaction was filed on 11 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
€89,4104,000 shares@ €22.35260.045% mcap47.8% of flow
Common Stock
SEC:0001171843-22-001832:0·
Ideal exit: 6 Dec 2022 (T+270)
04,438 shares0
Common Stock
SEC:0001171843-22-001812:0·
€97,5882,850 shares@ €34.24150.073% mcap100.0% of flow
Common Stock
SEC:0001171843-21-005933·
Ideal exit: 8 May 2022 (T+270)
€97,5882,850 shares@ €34.24150.049% mcap52.2% of flow
Common Stock
SEC:0001171843-21-005933:0·
Ideal exit: 8 May 2022 (T+270)
03,859 shares0
Common Stock
SEC:0001171843-21-005897·
03,859 shares0
Common Stock
SEC:0001171843-21-005897:0·
6 of 6 declarations
About Levitz Michael L
Michael L. Levitz is the Executive Vice President, Chief Financial Officer, and Treasurer of Anika Therapeutics, Inc. He oversees the financial management of the company, including budgeting and financial reporting. Michael plays a key role in Anika's financial strategy.
